Medirom Healthcare Technologies (MRM) Debt to Equity (2019 - 2024)
Medirom Healthcare Technologies has reported Debt to Equity over the past 6 years, most recently at $1.48 for Q4 2024.
- Quarterly results put Debt to Equity at $1.48 for Q4 2024, down 78.43% from a year ago — trailing twelve months through Dec 2024 was $1.48 (down 78.43% YoY), and the annual figure for FY2024 was $1.48, down 78.43%.
- Debt to Equity for Q4 2024 was $1.48 at Medirom Healthcare Technologies, down from $6.88 in the prior quarter.
- Over the last five years, Debt to Equity for MRM hit a ceiling of $6.88 in Q4 2023 and a floor of -$21.03 in Q4 2022.
- Median Debt to Equity over the past 5 years was $1.48 (2024), compared with a mean of -$3.04.
- Biggest five-year swings in Debt to Equity: crashed 382.18% in 2022 and later soared 132.71% in 2023.
- Medirom Healthcare Technologies' Debt to Equity stood at $1.85 in 2020, then plummeted by 335.32% to -$4.36 in 2021, then crashed by 382.18% to -$21.03 in 2022, then soared by 132.71% to $6.88 in 2023, then plummeted by 78.43% to $1.48 in 2024.
- The last three reported values for Debt to Equity were $1.48 (Q4 2024), $6.88 (Q4 2023), and -$21.03 (Q4 2022) per Business Quant data.